Catatonia Diagnosis and Management
Primary Diagnosis
- The American Academy of Child and Adolescent Psychiatry recommends that catatonia be diagnosed based on classic catatonic features, including mutism, stupor, staring, withdrawal, minimal environmental responsiveness, and thought blocking, as documented on admission 1
- A positive lorazepam challenge, with clinical improvement and verbalization by day 3 of treatment, is diagnostic and therapeutic confirmation of catatonia 1
- The presence of underlying Bipolar I Disorder, with seven prior involuntary psychiatric admissions for psychotic episodes, establishes the underlying psychiatric etiology 2
- Acute psychotic exacerbation, characterized by disorganized behavior, poverty of speech, internal preoccupation, and inability to care for oneself, indicates active psychosis 3
Critical Differential Diagnoses
- Malignant catatonia is a life-threatening emergency that requires immediate escalation to ECT if autonomic signs develop, with a mortality risk if left untreated 4, 5
- Neuroleptic Malignant Syndrome (NMS) presents with rigidity, hyperthermia, elevated creatine kinase, and recent antipsychotic exposure, and can be clinically indistinguishable from malignant catatonia 4
- Substance-Induced Psychotic Disorder with Catatonia should be considered, but the patient's catatonia persists beyond the acute intoxication/withdrawal window, and the response pattern is more consistent with primary psychiatric illness 3, 6
Secondary Diagnoses
- The patient has co-occurring Cannabis Use Disorder, Alcohol Use Disorder, and Methamphetamine Use Disorder, which complicate psychiatric management and increase relapse risk 3
- Type 2 Diabetes Mellitus, with hyperglycemia indicating poor control, requires metabolic monitoring 5, 7
- Hypertension, with elevated BP requiring monitoring and treatment, is also present 5, 7
Treatment Algorithm
- The American Academy of Child and Adolescent Psychiatry recommends continuing lorazepam for catatonia, with dose escalation up to 24 mg/day if symptoms persist 1
- Antipsychotic management for underlying psychosis should continue, with cross-titration from quetiapine to risperidone, and consideration of long-acting injectable 1
- If catatonia persists beyond 7-10 days, ECT should be considered, as it is the treatment of choice for refractory catatonia, malignant catatonia, or when medications cannot be tolerated 4, 5, 9
Critical Pitfalls to Avoid
- Malignant catatonia should not be missed, and vital signs should be monitored closely for autonomic instability, which requires immediate ECT 4
- Catatonia should not be confused with delirium, which is characterized by fluctuating consciousness, and requires different management 6
- ECT should not be delayed if benzodiazepines fail, as waiting too long increases morbidity and mortality 4
- Metabolic monitoring should not be overlooked, particularly in patients with diabetes and those taking antipsychotics 5, 7, 8